Value of biopsy by contrast-enhanced ultrasound in diagnosis of nature of type 4 thyroid nodules by thyroid imaging reporting and data system
-
摘要:目的
探讨超声造影(CEUS)在细针穿刺活检(FNA)指导甲状腺影像报告和数据系统(TI-RADS)4类甲状腺结节性质诊断中的价值。
方法选取120例TI-RADS 4类甲状腺结节患者作为研究对象。60例患者行CEUS指导下FNA (CEUS组), 另外60例患者行常规超声指导下的FNA (常规超声组)。以病理结果为金标准,采用Kappa一致性检验,分析常规超声指导FNA、CEUS指导FNA对TI-RADS 4类甲状腺结节性质诊断的一致性。
结果120例TI-RADS 4类甲状腺结节患者(138个结节)经病理确诊85个恶性结节,良性结节53个。其中, CEUS组良性结节28个,恶性结节42个(甲状腺乳头状癌40个,髓样癌2个),常规超声组良性结节25个,恶性结节43个(甲状腺乳头状癌39个,髓样癌4个)。常规超声指导FNA诊断TI-RADS 4类甲状腺恶性结节的误诊率、漏诊率分别为3.62%、5.07%。CEUS指导FNA诊断TI-RADS 4类甲状腺恶性结节的误诊率、漏诊率分别为2.17%、2.90%。常规超声指导FNA诊断TI-RADS 4类甲状腺结节性质的敏感度、特异度、准确度分别为83.72%、80.00%、82.35%, Kappa值为0.627。CEUS指导FNA诊断TI-RADS 4类甲状腺结节性质的敏感度、特异度、准确度分别为90.48%、89.29%、90.00%, Kappa值为0.793。经病理检测,常规超声指导FNA、CEUS指导FNA诊断TI-RADS 4类甲状腺恶性结节的符合率分别为79.07%、83.33%, Kappa值分别为0.719、0.786。
结论CEUS指导FNA时,可通过提供高分辨率、实时动态的影像信息,提高诊断TI-RADS 4类甲状腺结节性质的敏感度和特异度。
Abstract:ObjectiveTo investigate the value of contrast-enhanced ultrasound (CEUS) guided fine needle aspiration (FNA) in diagnosing the nature of type 4 thyroid nodules by thyroid imaging reporting and data system (TI-RADS).
MethodsA total of 120 patients with TI-RADS type 4 thyroid nodules were selected as subjects. Sixty patients underwent CEUS-guided FNA (CEUS group), while the other 60 patients underwent conventional ultrasound-guided FNA (conventional ultrasound group). Using pathological results as the gold standard, Kappa consistency tests were used to analyze the diagnostic consistency of conventional ultrasound-guided FNA and CEUS-guided FNA for TI-RADS type 4 thyroid nodules.
ResultsAmong 120 patients with TI-RADS type 4 thyroid nodules (138 nodules), 85 malignant nodules and 53 benign nodules were confirmed by pathology. In the CEUS group, there were 28 benign nodules and 42 malignant nodules (40 papillary thyroid carcinomas and 2 medullary carcinomas). In the conventional ultrasound group, there were 25 benign nodules and 43 malignant nodules (39 papillary thyroid carcinomas and 4 medullary carcinomas). The false positive rate and false negative rate of conventional ultrasound-guided FNA for diagnosing malignant TI-RADS type 4 thyroid nodules were 3.62% and 5.07%, respectively. For CEUS-guided FNA, the rates were 2.17% and 2.90%, respectively. The sensitivity, specificity and accuracy of conventional ultrasound-guided FNA for diagnosing the nature of TI-RADS type 4 thyroid nodules were 83.72%, 80.00% and 82.35%, respectively, with Kappa value of 0.627. For CEUS-guided FNA, these values were 90.48%, 89.29% and 90.00%, respectively, with Kappa value of 0.793. Based on pathological examination, the diagnostic agreement rates for malignant TI-RADS type 4 thyroid nodules were 79.07% for conventional ultrasound-guided FNA and 83.33% for CEUS-guided FNA, with Kappa values of 0.719 and 0.786, respectively.
ConclusionCEUS-guided FNA can provide high-resolution, real-time dynamic imaging information, thereby improving the sensitivity and specificity of diagnosing the nature of TI-RADS type 4 thyroid nodules.
-
-
表 1 常规超声指导FNA的病理诊断结果
个 常规超声指导FNA 病理检查 合计 恶性(n=43) 良性(n=25) 恶性 36 5 41 良性 7 20 27 表 2 CEUS指导FNA的病理诊断结果
个 CEUS指导FNA 病理检查 合计 恶性(n=42) 良性(n=28) 恶性 38 3 41 良性 4 25 29 表 3 常规超声、CEUS指导FNA诊断TI-RADS 4类甲状腺结节性质的一致性分析
检查方法 敏感度/% 特异度/% 准确度/% 阳性预测值/% 阴性预测值/% Kappa 常规超声指导FNA 83.72 80.00 82.35 87.80 74.07 0.627 CEUS指导FNA 90.48 89.29 90.00 92.68 86.21 0.793 表 4 常规超声指导FNA对TI-RADS 4类甲状腺恶性结节的诊断
常规超声指导FNA 金标准 Kappa 良性(n=25) 甲状腺乳头状癌(n=39) 髓样癌(n=4) 良性 20 7 0 0.719 甲状腺乳头状癌 2 31 1 髓样癌 3 1 3 表 5 CEUS指导FNA对TI-RADS 4类甲状腺恶性结节的诊断
CEUS指导FNA 金标准 Kappa 良性(n=28) 甲状腺乳头状癌(n=40) 髓样癌(n=2) 良性 23 6 0 0.786 甲状腺乳头状癌 3 33 0 髓样癌 2 1 2 -
[1] 吴秀南, 刘小蓝, 林志健. VTIQ、UE联合CEUS对甲状腺TI-RADS 4类结节良恶性的评估价值[J]. 川北医学院学报, 2023, 38(2): 269-272. doi: 10.3969/j.issn.1005-3697.2023.02.030 [2] 韩娟, 张立文, 宋金岭, 等. 局灶性强回声超声征象在鉴别TI-RADS 4类甲状腺结节良恶性中的临床价值[J]. 临床超声医学杂志, 2023, 25(6): 456-459. doi: 10.3969/j.issn.1008-6978.2023.06.010 [3] 侯婷婷, 张红伟, 夏燕妮. 超声TI-RADS分级对甲状腺结节性质的评估价值及其与BMI、FBG、HbA1c水平的相关性[J]. 中国老年学杂志, 2023, 43(10): 2365-2369. doi: 10.3969/j.issn.1005-9202.2023.10.018 [4] DUFOUR J P, ALLERS C, SCHIRO F, et al. Comparison of fine-needle aspiration techniques[J]. J Med Primatol, 2023, 52(6): 400-404. doi: 10.1111/jmp.12676
[5] 邵春晖, 罗永科, 姜珏, 等. 超声造影特征及定量参数诊断C-TIRADS 4类细针穿刺细胞学检查不明确甲状腺结节的价值[J]. 实用临床医药杂志, 2023, 27(16): 1-6. doi: 10.7619/jcmp.20230897 [6] WANG S H, LI Z Q, LIAO L M, et al. DPAM-PSPNet: ultrasonic image segmentation of thyroid nodule based on dual-path attention mechanism[J]. Phys Med & Biol, 2023, 68(16).
[7] 任卫东, 常才. 超声诊断学[M]. 4版. 北京: 人民卫生出版社, 2022: 120-125. [8] ALI S Z, BALOCH Z W, COCHAND-PRIOLLET B, et al. The 2023 Bethesda system for reporting thyroid cytopathology[J]. Thyroid, 2023, 33(9): 1039-1044.
[9] 袁杰, 张华, 张丹峰, 等. 影响改良式超声引导下甲状腺结节粗针穿刺活检准确率因素的Logistic回归分析[J]. 现代肿瘤医学, 2023, 31(20): 3781-3784. doi: 10.3969/j.issn.1672-4992.2023.20.011 [10] 巴妍·谢开, 沙娅·衣利亚斯, 马依拉·佰拜, 等. 实时剪切波弹性成像结合血清胸苷激酶1和甲状腺球蛋白检测对甲状腺结节性质的预测效能分析[J]. 中国耳鼻咽喉头颈外科, 2023, 30(1): 1-4. [11] 龚黎, 李霞, 方晗, 等. 基于优化卷积网络Faster R-CNN自动检测甲状腺结节超声图像的研究[J]. 中国超声医学杂志, 2023, 39(2): 209-213. doi: 10.3969/j.issn.1002-0101.2023.02.028 [12] 何糠, 韦馨, 李金, 等. SWE联合CEUS在甲状腺结节鉴别诊断中的应用价值[J]. 保健医学研究与实践, 2023, 20(6): 66-71. [13] 胡加银, 李陶, 夏纪筑. C-TIRADS、超声造影、BRAFV600E基因对TBSRTC Ⅲ类甲状腺结节诊断价值分析[J]. 实用医学杂志, 2022, 38(21): 2739-2744. doi: 10.3969/j.issn.1006-5725.2022.21.019 [14] 童瑾, 黄磊, 李军, 等. 声触诊组织量化成像联合超声造影鉴别诊断TI-RADS 4类良恶性甲状腺结节[J]. 中国医学影像技术, 2020, 36(6): 828-833. [15] 吴秀南, 刘小蓝, 张亚庆. CEUS联合US-FNA对老年甲状腺结节良恶性的诊断价值评估[J]. 中国老年学杂志, 2023, 43(17): 4146-4149. [16] 宋建明, 陈花, 游宇光, 等. 超声造影联合超声弹性成像在甲状腺TI-RADS 3~4类结节中的应用[J]. 中国超声医学杂志, 2023, 39(9): 969-973. [17] 庄晓晨, 宋涛, 李智铭, 等. 高增强型超声造影特征判断甲状腺可疑恶性结节的单因素及多因素分析[J]. 新疆医科大学学报, 2023, 46(4): 490-494. [18] 孙思杰, 覃左涛, 文思, 等. 超声造影与细针穿刺细胞学活检对甲状腺微小癌的诊断价值[J]. 中国医学装备, 2023, 20(6): 72-76. -
期刊类型引用(2)
1. 王爱亮. 超敏C反应蛋白、二聚体、脑利钠肽前体在房颤合并慢性心力衰竭患者的表达. 辽宁医学杂志. 2020(04): 16-18 . 百度学术
2. 王新康,刘洪旭,马丽红,杨燕秋. 卡维地洛联合胺碘酮治疗心律失常的疗效及对患者心功能、hs-CRP的影响. 临床医学工程. 2018(10): 1351-1352 . 百度学术
其他类型引用(3)
计量
- 文章访问数: 39
- HTML全文浏览量: 4
- PDF下载量: 7
- 被引次数: 5